» Articles » PMID: 20697097

Circulating MiRNA Signatures: Promising Prognostic Tools for Cancer

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2010 Aug 11
PMID 20697097
Citations 28
Authors
Affiliations
Soon will be listed here.
Citing Articles

A review of prognostic and predictive biomarkers in breast cancer.

Tarighati E, Keivan H, Mahani H Clin Exp Med. 2022; 23(1):1-16.

PMID: 35031885 DOI: 10.1007/s10238-021-00781-1.


Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma.

Chen S, Fu Z, Wen S, Yang X, Yu C, Zhou W Front Genet. 2021; 12:666306.

PMID: 34163524 PMC: 8215616. DOI: 10.3389/fgene.2021.666306.


miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer.

Yu X, Zhang X, Wang G, Wang B, Ding Y, Zhao J Cancer Cell Int. 2020; 20(1):534.

PMID: 33292230 PMC: 7641844. DOI: 10.1186/s12935-020-01623-y.


miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma.

Chen X, Lou N, Ruan A, Qiu B, Yan Y, Wang X Oncol Lett. 2018; 16(2):1666-1674.

PMID: 30008851 PMC: 6036413. DOI: 10.3892/ol.2018.8874.


The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Vetter N, Kolb E, Mills C, Sampson V Mol Cancer Res. 2017; 15(7):953-964.

PMID: 28275089 PMC: 5500423. DOI: 10.1158/1541-7786.MCR-16-0372.